Eikon Therapeutics, Inc. Common Stock (EIKN) ownership: Top institutional holder: FMR LLC ($40.59M). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 3836830.00 | $40.59M | 2026-03-31 |
| BlackRock, Inc. | 3319379.00 | $35.12M | 2026-03-31 |
| Foresite Capital Management IV, LLC | 1943682.00 | $20.56M | 2026-03-31 |
| Merck & Co., Inc. | 1666666.00 | $17.63M | 2026-03-31 |
| Foresite Capital Management V, LLC | 1318983.00 | $13.95M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 1222487.00 | $12.93M | 2026-03-31 |
| Capital World Investors | 1143637.00 | $12.10M | 2026-03-31 |
| ALLIANCEBERNSTEIN L.P. | 1022188.00 | $10.81M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-02-06 |
Back to EIKN overview · EIKN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.